Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
Biallelic mutations in KATNAL2 cause male infertility due to oligo-astheno-teratozoospermia.

Clinical genetics

Wei X, Liu W, Zhu X, Li Y, Zhang X, Chen J, Isachenko V, Sha Y, Lu Z.
PMID: 34096614
Clin Genet. 2021 Oct;100(4):376-385. doi: 10.1111/cge.14009. Epub 2021 Jun 11.

Oligo-astheno-teratozoospermia (OAT) is a common cause of male infertility, and most of idiopathic OAT patients are thought to be caused by genetic defects. Here, we recruited 38 primary infertile patients with the OAT phenotype and 40 adult men with...

Cite
Wei X, Liu W, Zhu X, et al. Biallelic mutations in KATNAL2 cause male infertility due to oligo-astheno-teratozoospermia. Clin Genet. 2021;100(4):376-385doi: 10.1111/cge.14009.
Wei, X., Liu, W., Zhu, X., Li, Y., Zhang, X., Chen, J., Isachenko, V., Sha, Y., & Lu, Z. (2021). Biallelic mutations in KATNAL2 cause male infertility due to oligo-astheno-teratozoospermia. Clinical genetics, 100(4), 376-385. https://doi.org/10.1111/cge.14009
Wei, Xiaoli, et al. "Biallelic mutations in KATNAL2 cause male infertility due to oligo-astheno-teratozoospermia." Clinical genetics vol. 100,4 (2021): 376-385. doi: https://doi.org/10.1111/cge.14009
Wei X, Liu W, Zhu X, Li Y, Zhang X, Chen J, Isachenko V, Sha Y, Lu Z. Biallelic mutations in KATNAL2 cause male infertility due to oligo-astheno-teratozoospermia. Clin Genet. 2021 Oct;100(4):376-385. doi: 10.1111/cge.14009. Epub 2021 Jun 11. PMID: 34096614.
Copy Download .nbib Format: NLM
New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer.

Cryobiology

Petrushko M, Yurchuk T, Todorov P, Hristova E, Piniaiev V, Isachenko E, Rahimi G, Mallmann P, Isachenko V.
PMID: 34606824
Cryobiology. 2021 Dec;103:39-44. doi: 10.1016/j.cryobiol.2021.09.013. Epub 2021 Oct 02.

Data about cryoprotectant-free cryopreservation of human ICSI spermatozoa are limited. The aim of this investigation was to compare two technologies for cryopreservation of spermatozoa from men with oligoasthenoteratozoospermia: standard conventional freezing with 5% glycerol (freezing in glycerol) and cryoprotectant-free...

Cite
Petrushko M, Yurchuk T, Todorov P, et al. New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology. 2021;103:39-44doi: 10.1016/j.cryobiol.2021.09.013.
Petrushko, M., Yurchuk, T., Todorov, P., Hristova, E., Piniaiev, V., Isachenko, E., Rahimi, G., Mallmann, P., & Isachenko, V. (2021). New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology, 10339-44. https://doi.org/10.1016/j.cryobiol.2021.09.013
Petrushko, Maryna, et al. "New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer." Cryobiology vol. 103 (2021): 39-44. doi: https://doi.org/10.1016/j.cryobiol.2021.09.013
Petrushko M, Yurchuk T, Todorov P, Hristova E, Piniaiev V, Isachenko E, Rahimi G, Mallmann P, Isachenko V. New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology. 2021 Dec;103:39-44. doi: 10.1016/j.cryobiol.2021.09.013. Epub 2021 Oct 02. PMID: 34606824.
Copy Download .nbib Format: NLM
Pathogenic Variants in .

Frontiers in cell and developmental biology

Sha Y, Liu W, Li L, Serafimovski M, Isachenko V, Li Y, Chen J, Zhao B, Wang Y, Wei X.
PMID: 34422805
Front Cell Dev Biol. 2021 Aug 06;9:676246. doi: 10.3389/fcell.2021.676246. eCollection 2021.

Acephalic spermatozoa syndrome is a rare type of teratozoospermia, but its pathogenesis is largely unknown. Here, we performed whole-exome sequencing for 34 patients with acephalic spermatozoa syndrome and identified pathogenic variants in the X-linked gene,

Cite
Sha Y, Liu W, Li L, et al. Pathogenic Variants in . Front Cell Dev Biol. 2021;9:676246doi: 10.3389/fcell.2021.676246.
Sha, Y., Liu, W., Li, L., Serafimovski, M., Isachenko, V., Li, Y., Chen, J., Zhao, B., Wang, Y., & Wei, X. (2021). Pathogenic Variants in . Frontiers in cell and developmental biology, 9676246. https://doi.org/10.3389/fcell.2021.676246
Sha, Yanwei, et al. "Pathogenic Variants in ." Frontiers in cell and developmental biology vol. 9 (2021): 676246. doi: https://doi.org/10.3389/fcell.2021.676246
Sha Y, Liu W, Li L, Serafimovski M, Isachenko V, Li Y, Chen J, Zhao B, Wang Y, Wei X. Pathogenic Variants in . Front Cell Dev Biol. 2021 Aug 06;9:676246. doi: 10.3389/fcell.2021.676246. eCollection 2021. PMID: 34422805; PMCID: PMC8377740.
Copy Download .nbib Format: NLM
High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic.

Cryobiology

Isachenko V, Isachenko E, Mallmann P, Rahimi G.
PMID: 34571024
Cryobiology. 2021 Dec;103:1-6. doi: 10.1016/j.cryobiol.2021.09.009. Epub 2021 Sep 25.

Cryopreservation and re-transplantation of ovarian tissue after anticancer treatment is important medical technology. Today, during a pandemic, the risk of contamination of transplanted cells with SARS-CoV-2 virus is extremely high. Data about cryo-resistance (virulence and/or infectivity) of SARS-CoV-2 are...

Cite
Isachenko V, Isachenko E, Mallmann P, et al. High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology. 2021;103:1-6doi: 10.1016/j.cryobiol.2021.09.009.
Isachenko, V., Isachenko, E., Mallmann, P., & Rahimi, G. (2021). High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology, 1031-6. https://doi.org/10.1016/j.cryobiol.2021.09.009
Isachenko, Vladimir, et al. "High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic." Cryobiology vol. 103 (2021): 1-6. doi: https://doi.org/10.1016/j.cryobiol.2021.09.009
Isachenko V, Isachenko E, Mallmann P, Rahimi G. High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology. 2021 Dec;103:1-6. doi: 10.1016/j.cryobiol.2021.09.009. Epub 2021 Sep 25. PMID: 34571024; PMCID: PMC8463116.
Copy Download .nbib Format: NLM
New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer.

Cryobiology

Petrushko M, Yurchuk T, Todorov P, Hristova E, Piniaiev V, Isachenko E, Rahimi G, Mallmann P, Isachenko V.
PMID: 34606824
Cryobiology. 2021 Oct 02; doi: 10.1016/j.cryobiol.2021.09.013. Epub 2021 Oct 02.

Data about cryoprotectant-free cryopreservation of human ICSI spermatozoa are limited. The aim of this investigation was to compare two technologies for cryopreservation of spermatozoa from men with oligoasthenoteratozoospermia: standard conventional freezing with 5% glycerol (freezing in glycerol) and cryoprotectant-free...

Cite
Petrushko M, Yurchuk T, Todorov P, et al. New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology. 2021;doi: 10.1016/j.cryobiol.2021.09.013.
Petrushko, M., Yurchuk, T., Todorov, P., Hristova, E., Piniaiev, V., Isachenko, E., Rahimi, G., Mallmann, P., & Isachenko, V. (2021). New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology, . https://doi.org/10.1016/j.cryobiol.2021.09.013
Petrushko, Maryna, et al. "New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer." Cryobiology vol. (2021). doi: https://doi.org/10.1016/j.cryobiol.2021.09.013
Petrushko M, Yurchuk T, Todorov P, Hristova E, Piniaiev V, Isachenko E, Rahimi G, Mallmann P, Isachenko V. New method for cryoprotectant-free freezing of human oligoasthenoteratozoospremic spermatozoa with high-molecular polymer. Cryobiology. 2021 Oct 02; doi: 10.1016/j.cryobiol.2021.09.013. Epub 2021 Oct 02. PMID: 34606824.
Copy Download .nbib Format: NLM
Influence of Risk Factors for Male Infertility on Sperm Protein Composition.

International journal of molecular sciences

Bisconti M, Simon JF, Grassi S, Leroy B, Martinet B, Arcolia V, Isachenko V, Hennebert E.
PMID: 34884971
Int J Mol Sci. 2021 Dec 06;22(23). doi: 10.3390/ijms222313164.

Male infertility is a common health problem that can be influenced by a host of lifestyle risk factors such as environment, nutrition, smoking, stress, and endocrine disruptors. These effects have been largely demonstrated on sperm parameters (e.g., motility, numeration,...

Cite
Bisconti M, Simon JF, Grassi S, et al. Influence of Risk Factors for Male Infertility on Sperm Protein Composition. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313164.
Bisconti, M., Simon, J. F., Grassi, S., Leroy, B., Martinet, B., Arcolia, V., Isachenko, V., & Hennebert, E. (2021). Influence of Risk Factors for Male Infertility on Sperm Protein Composition. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313164
Bisconti, Marie, et al. "Influence of Risk Factors for Male Infertility on Sperm Protein Composition." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313164
Bisconti M, Simon JF, Grassi S, Leroy B, Martinet B, Arcolia V, Isachenko V, Hennebert E. Influence of Risk Factors for Male Infertility on Sperm Protein Composition. Int J Mol Sci. 2021 Dec 06;22(23). doi: 10.3390/ijms222313164. PMID: 34884971; PMCID: PMC8658491.
Copy Download .nbib Format: NLM
Influence of Risk Factors for Male Infertility on Sperm Protein Composition.

International journal of molecular sciences

Bisconti M, Simon JF, Grassi S, Leroy B, Martinet B, Arcolia V, Isachenko V, Hennebert E.
PMID: 34884971
Int J Mol Sci. 2021 Dec 06;22(23). doi: 10.3390/ijms222313164.

Male infertility is a common health problem that can be influenced by a host of lifestyle risk factors such as environment, nutrition, smoking, stress, and endocrine disruptors. These effects have been largely demonstrated on sperm parameters (e.g., motility, numeration,...

Cite
Bisconti M, Simon JF, Grassi S, et al. Influence of Risk Factors for Male Infertility on Sperm Protein Composition. Int J Mol Sci. 2021;22(23)doi: 10.3390/ijms222313164.
Bisconti, M., Simon, J. F., Grassi, S., Leroy, B., Martinet, B., Arcolia, V., Isachenko, V., & Hennebert, E. (2021). Influence of Risk Factors for Male Infertility on Sperm Protein Composition. International journal of molecular sciences, 22(23), . https://doi.org/10.3390/ijms222313164
Bisconti, Marie, et al. "Influence of Risk Factors for Male Infertility on Sperm Protein Composition." International journal of molecular sciences vol. 22,23 (2021). doi: https://doi.org/10.3390/ijms222313164
Bisconti M, Simon JF, Grassi S, Leroy B, Martinet B, Arcolia V, Isachenko V, Hennebert E. Influence of Risk Factors for Male Infertility on Sperm Protein Composition. Int J Mol Sci. 2021 Dec 06;22(23). doi: 10.3390/ijms222313164. PMID: 34884971.
Copy Download .nbib Format: NLM
Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma.

Oncology (Williston Park, N.Y.)

Salama M, Isachenko E, Rahimi G, Mallmann P, Isachenko V.
PMID: 34147055
Oncology (Williston Park). 2021 Jun 19;35(6):332-334. doi: 10.46883/ONC.2021.3506.0332.

A nulliparous woman, age 25 years, had received a diagnosis of non-Hodgkin lymphoma (NHL) and now presented with stage IIA diffuse large B-cell lymphoma (DLBCL). According to her hematological oncologist's treatment plan, chemotherapy had to start immediately (within 1...

Cite
Salama M, Isachenko E, Rahimi G, et al. Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma. Oncology (Williston Park). 2021;35(6):332-334doi: 10.46883/ONC.2021.3506.0332.
Salama, M., Isachenko, E., Rahimi, G., Mallmann, P., & Isachenko, V. (2021). Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma. Oncology (Williston Park, N.Y.), 35(6), 332-334. https://doi.org/10.46883/ONC.2021.3506.0332
Salama, Mahmoud, et al. "Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma." Oncology (Williston Park, N.Y.) vol. 35,6 (2021): 332-334. doi: https://doi.org/10.46883/ONC.2021.3506.0332
Salama M, Isachenko E, Rahimi G, Mallmann P, Isachenko V. Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma. Oncology (Williston Park). 2021 Jun 19;35(6):332-334. doi: 10.46883/ONC.2021.3506.0332. PMID: 34147055.
Copy Download .nbib Format: NLM
A passive BCI for monitoring the intentionality of the gaze-based moving object selection.

Journal of neural engineering

Zhao DG, Vasilyev AN, Kozyrskiy BL, Melnichuk EV, Isachenko AV, Velichkovsky BM, Shishkin SL.
PMID: 33418554
J Neural Eng. 2021 Jan 08; doi: 10.1088/1741-2552/abda09. Epub 2021 Jan 08.

OBJECTIVE: The use of an electroencephalogram (EEG) anticipation-related component, the expectancy wave (E-wave), in brain-machine interaction was proposed more than 50 years ago. This possibility was not explored for decades, but recently it was shown that voluntary attempts to...

Cite
Zhao DG, Vasilyev AN, Kozyrskiy BL, et al. A passive BCI for monitoring the intentionality of the gaze-based moving object selection. J Neural Eng. 2021;doi: 10.1088/1741-2552/abda09.
Zhao, D. G., Vasilyev, A. N., Kozyrskiy, B. L., Melnichuk, E. V., Isachenko, A. V., Velichkovsky, B. M., & Shishkin, S. L. (2021). A passive BCI for monitoring the intentionality of the gaze-based moving object selection. Journal of neural engineering, . https://doi.org/10.1088/1741-2552/abda09
Zhao, Darisy Guanlinovich, et al. "A passive BCI for monitoring the intentionality of the gaze-based moving object selection." Journal of neural engineering vol. (2021). doi: https://doi.org/10.1088/1741-2552/abda09
Zhao DG, Vasilyev AN, Kozyrskiy BL, Melnichuk EV, Isachenko AV, Velichkovsky BM, Shishkin SL. A passive BCI for monitoring the intentionality of the gaze-based moving object selection. J Neural Eng. 2021 Jan 08; doi: 10.1088/1741-2552/abda09. Epub 2021 Jan 08. PMID: 33418554.
Copy Download .nbib Format: NLM
Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration.

Human fertility (Cambridge, England)

Chen J, Todorov P, Isachenko E, Rahimi G, Mallmann P, Isachenko V.
PMID: 33648431
Hum Fertil (Camb). 2021 Mar 01;1-21. doi: 10.1080/14647273.2021.1885756. Epub 2021 Mar 01.

The proportion of cancer patients that survive is increasing because of improvements in cancer therapy. However, some cancer treatments, such as chemo- and radio-therapies, can cause considerable damage to reproductive function. The issue of fertility is paramount for women...

Cite
Chen J, Todorov P, Isachenko E, et al. Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration. Hum Fertil (Camb). 2021;1-21doi: 10.1080/14647273.2021.1885756.
Chen, J., Todorov, P., Isachenko, E., Rahimi, G., Mallmann, P., & Isachenko, V. (2021). Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration. Human fertility (Cambridge, England), 1-21. https://doi.org/10.1080/14647273.2021.1885756
Chen, Jing, et al. "Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration." Human fertility (Cambridge, England) vol. (2021): 1-21. doi: https://doi.org/10.1080/14647273.2021.1885756
Chen J, Todorov P, Isachenko E, Rahimi G, Mallmann P, Isachenko V. Construction and cryopreservation of an artificial ovary in cancer patients as an element of cancer therapy and a promising approach to fertility restoration. Hum Fertil (Camb). 2021 Mar 01;1-21. doi: 10.1080/14647273.2021.1885756. Epub 2021 Mar 01. PMID: 33648431.
Copy Download .nbib Format: NLM
High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic.

Cryobiology

Isachenko V, Isachenko E, Mallmann P, Rahimi G.
PMID: 34571024
Cryobiology. 2021 Dec;103:1-6. doi: 10.1016/j.cryobiol.2021.09.009. Epub 2021 Sep 25.

Cryopreservation and re-transplantation of ovarian tissue after anticancer treatment is important medical technology. Today, during a pandemic, the risk of contamination of transplanted cells with SARS-CoV-2 virus is extremely high. Data about cryo-resistance (virulence and/or infectivity) of SARS-CoV-2 are...

Cite
Isachenko V, Isachenko E, Mallmann P, et al. High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology. 2021;103:1-6doi: 10.1016/j.cryobiol.2021.09.009.
Isachenko, V., Isachenko, E., Mallmann, P., & Rahimi, G. (2021). High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology, 1031-6. https://doi.org/10.1016/j.cryobiol.2021.09.009
Isachenko, Vladimir, et al. "High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic." Cryobiology vol. 103 (2021): 1-6. doi: https://doi.org/10.1016/j.cryobiol.2021.09.009
Isachenko V, Isachenko E, Mallmann P, Rahimi G. High cryo-resistance of SARS-CoV-2 virus: Increased risk of re-contamination at transplantation of cryopreserved ovarian tissue after COVID-19 pandemic. Cryobiology. 2021 Dec;103:1-6. doi: 10.1016/j.cryobiol.2021.09.009. Epub 2021 Sep 25. PMID: 34571024; PMCID: PMC8463116.
Copy Download .nbib Format: NLM
Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing.

Geburtshilfe und Frauenheilkunde

Isachenko V, Dittrich R, Keck G, Isachenko E, Rahimi G, van der Ven H, Montag M, Hoffmann I, Müller A, Distler W, Beckmann MW, Mallmann P.
PMID: 25258453
Geburtshilfe Frauenheilkd. 2012 Oct;72(10):927-932. doi: 10.1055/s-0032-1327812.

No abstract available.

Cite
Isachenko V, Dittrich R, Keck G, et al. Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing. Geburtshilfe Frauenheilkd. 2012;72(10):927-932doi: 10.1055/s-0032-1327812.
Isachenko, V., Dittrich, R., Keck, G., Isachenko, E., Rahimi, G., van der Ven, H., Montag, M., Hoffmann, I., Müller, A., Distler, W., Beckmann, M. W., & Mallmann, P. (2012). Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing. Geburtshilfe und Frauenheilkunde, 72(10), 927-932. https://doi.org/10.1055/s-0032-1327812
Isachenko, V, et al. "Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing." Geburtshilfe und Frauenheilkunde vol. 72,10 (2012): 927-932. doi: https://doi.org/10.1055/s-0032-1327812
Isachenko V, Dittrich R, Keck G, Isachenko E, Rahimi G, van der Ven H, Montag M, Hoffmann I, Müller A, Distler W, Beckmann MW, Mallmann P. Cryopreservation of Ovarian Tissue: Detailed Description of Methods for Transport, Freezing and Thawing. Geburtshilfe Frauenheilkd. 2012 Oct;72(10):927-932. doi: 10.1055/s-0032-1327812. PMID: 25258453; PMCID: PMC4168540.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries